相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety of growth hormoneA combined registry analysis
Kirstine Stochholm et al.
CLINICAL ENDOCRINOLOGY (2018)
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus H. Gravholt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
Maria Victoria Borras Perez et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Patients' perceptions on the usability of the SurePal™self-injection device for Omnitrope®: a questionnaire-based observational study conducted in paediatric patients in France
Regis Coutant et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2017)
Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics
Kerstin Albertsson-Wikland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Growth hormone replacement in adults - current standards and new perspectives
Charlotte Hoybye et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Growth Hormone Dose-Dependent Pubertal Growth: A Randomized Trial in Short Children with Low Growth Hormone Secretion
Kerstin Albertsson-Wikland et al.
HORMONE RESEARCH IN PAEDIATRICS (2014)
Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope® in children requiring growth hormone treatment
Roland Pfaeffle et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2013)
Long-Term Mortality after Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study
Jean-Claude Carel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study
Lars Savendahl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope® for the treatment of adult patients with growth hormone deficiency
Paolo Beck-Peccoz et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2012)
Long-term Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Spanish Growth Hormone Deficient Children: Results of a Phase III Study
J. Lopez-Siguero et al.
ADVANCES IN THERAPY (2011)
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
Mark E. Molitch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Adult Height in Children with Growth Hormone Deficiency: A Randomized, Controlled, Growth Hormone Dose-Response Trial
Theo C. J. Sas et al.
HORMONE RESEARCH IN PAEDIATRICS (2010)
The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children
Berit Kristrom et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2009)
Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope (R) in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study
T. Romer et al.
HORMONE RESEARCH (2009)
Growth Hormone (GH) Dosing during Catch-Up Growth Guided by Individual Responsiveness Decreases Growth Response Variability in Prepubertal Children with GH Deficiency or Idiopathic Short Stature
Berit Kristrom et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Biosimilar therapeutics-what do we need to consider?
Huub d Schellekens
CLINICAL KIDNEY JOURNAL (2009)
Dose-Dependent Effect of Growth Hormone on Final Height in Children with Short Stature without Growth Hormone Deficiency
Kerstin Albertsson-Wikland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age
Jovanna Dahlgren et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2007)
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia
Ken K. Y. Ho
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Immunogenicity of biopharmaceuticals
Michele Kessler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Update of guidelines for the use of growth hormone in children: The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee
TA Wilson et al.
JOURNAL OF PEDIATRICS (2003)
Prediction of response to growth hormone treatment in short children born small for gestational age: Analysis of data from KIGS (Pharmacia international growth database)
MB Ranke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Bioequivalence and the immunogenicity of biopharmaceuticals
H Schellekens
NATURE REVIEWS DRUG DISCOVERY (2002)
Immunogenicity of rDNA-derived pharmaceuticals
JC Ryff et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
分享论文
